trial

REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach to Core Beliefs in Psychosis

NCTId NCT07569471
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 38 (estimated)
Sponsored by University of Toronto
Primary completion 2027-08-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
38 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2026-03-31
Primary completion
2027-08-30
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
REFLECT: REFlecting on and Learning to Evaluate Core beliefs in real Time

Sponsors

University of TorontoLead Sponsor

Investigators

2
Micheal W Best, PhDPrincipal Investigator
Sean A Kidd, PhDStudy Director

Sites

1 total
Scarborough Village, Canada

Facts & assertions

4 sourced
Enrollment
38
Phase
NA
Primary Completion Date
2027-08-30
Status
RECRUITING
relationships
The graph out of here
drug
REFLECT: REFlecting on and Learning to Evaluate Core beliefs in real Time
drug
lead_sponsor
University of Toronto
company
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Schizophrenia
indication
Schizophrenia Spectrum & Other Psychotic Disorders
indication
investigator
Micheal W Best, PhD
person
Sean A Kidd, PhD
person